Novel Clinical Trial Designs in Oncology Drug Development

Jancarlo Durand

5 years ago

MedSource Head of Biometrics, Senior Clinical Research Associate, Zoran Antonijevic, presented, “Novel Clinical Trial Designs in Oncology Drug Development” at the 2019 Clinical Operations in Oncology Trials East Coast conference hosted by Arena International Events Group in Waltham, Massachusetts. During his presentation, Zoran discussed:

Importance of incorporating novel, more efficient designs in Oncology drug development
Master Protocols for more efficient early-stage development
Selected Phase 3 Adaptive Designs that reduce costs/timeline and/or improve the probability of success

Head of Biometrics at MedSource, Zoran Antonijevic has held executive positions in Pharmaceutical Companies and CROs and has designed more than 100 clinical trials in numerous therapeutic areas, many of which included adaptive designs. Zoran is a long-time Chair and leader of the DIA Adaptive Design Scientific Working Group. He has authored numerous papers and scientific presentations and was the editor of books “Optimization of Pharmaceutical R&D Programs and Portfolios” and “Platform Trials in Drug Development”.

Download the Presentation

To download the presentation, please submit the form below.

Full Name*
First Last
Email Address*
Phone Number
CAPTCHA
Name
This field is for validation purposes and should be left unchanged.